What are you looking for?

Need help finding what you are looking for? Contact Us

Compare

Free Samples

Home Market Research Reports Pharmaceutical

PUBLISHER: Polaris Market Research | PRODUCT CODE: 1463134

PUBLISHER: Polaris Market Research | PRODUCT CODE: 1463134

Anorexiants Market Share, Size, Trends, Industry Analysis Report, By Drug Class (Catecholamines, Serotonin); By Route of Administration; By End User; By Region; Segment Forecast, 2024 - 2032

PUBLISHED: March 24, 2024

PAGES: 118 Pages

DELIVERY TIME: 1-2 business days

ADD TO COMPARE

SELECT AN OPTION

The global anorexiants market size is expected to reach USD 1,403.13 million by 2032, according to a new study by Polaris Market Research. The report "Anorexiants Market Share, Size, Trends, Industry Analysis Report, By Drug Class (Catecholamines, Serotonin); By Route of Administration; By End User; By Region; Segment Forecast, 2024 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The growth of the global anorexiants market is highly attributable to the rising consumer interest in weight management, which, in a way, limits appetite. The availability of the class of drugs that suppress appetite is gaining consumers attention as a measure to control calorie intake, creating higher demand. This is driving the pharmaceutical companies to enhance their production capacity. For instance, in February 2024, Novo Holdings unveiled its strategy to acquire Catalent to promote the supply of Wegovy, a weight loss injection, and Ozempic, a diabetic shot, for $16.5 billion.

As the number of people suffering from obesity grows significantly in the future, there will be a huge demand for appetite management drugs in the marketplace during the study period. According to the World Obesity Federation Report 2023, about 4 million people, which is more than 50% of the global population, are estimated to be obese by 2035.

The growing gap between energy consumption and energy spent on physical activities is the building factor leading to the rise in obesity. The increase in the number of people opting for lifestyle modification, with a higher focus on body look due to the growing use of social media, is stimulating the demand for appetite-control medications, such as anorexiants. A 2023 study found that TikTok and Instagram have a significant influence in educating weight management among youth of color in the United States.

The prevalence of chronic diseases, such as cardiac arrest, type 2 diabetes, and certain cancers, among obese people is grabbing the attention of consumers to consult doctors for treatment, facilitating the need for obese medications, including anorexiants, in healthcare settings. According to the University of Colorado Boulder Research in 2023, obesity increases the risk of death from a minimum of 22% to a maximum of 91%. According to another study, losing weight by 5-10% with diet and physical activities among obese people lowered the risk of developing cardiovascular disease among obese adults.

The growing research studies focusing on the innovation of new medication formulations for the treatment of obesity and weight management are anticipated to showcase significant demand for anorexiants in the world. For instance, in November 2023, the U.S. Food and Drug Administration (FDA) announced the approval of a chronic weight management injection, Zepbound (tirzepatide). In January 2024, Eli Lilly announced its plan to introduce the obesity drug Mounjaro in India in the next year.

Anorexiants Market Report Highlights

The catecholamines segment is anticipated to witness the highest growth in the coming years due to its effective performance in boosting energy expenditure.

Oral segment accounted for the largest market share owing to its convenience in taking medication.

The hospitals segment is projected to experience a larger revenue share due to the presence of hospitals offering treatment for obese patients.

Asia Pacific is projected to register the fastest growth during the forecast period, attributable to the increasing incidence of obesity.

The global players include AstraZeneca, Aurobindo Pharma, Bausch Health Companies Inc., Cipla Inc., Currax Pharmaceuticals LLC, & Eisai Co., Ltd.

Polaris Market Research has segmented the anorexiants market report based on drug class, route of administration, end user and region:

Anorexiants, Drug Class Outlook (Revenue - USD Million, 2019 - 2032)

Catecholamines
Serotonin

Anorexiants, Route of Admission Outlook (Revenue - USD Million, 2019 - 2032)

Oral
Subcutaneous

Anorexiants, End User Outlook (Revenue - USD Million, 2019 - 2032)

Institutional sales
Hospitals
Clinics
Retail sales
Online pharmacies
Mail Order Pharmacies

Anorexiants, Regional Outlook (Revenue - USD Million, 2019 - 2032)

North America
U.S.
Canada
Europe
Germany
UK
France
Italy
Spain
Russia
Netherlands
Rest of Europe
Asia Pacific
China
India
Japan
South Korea
Indonesia
Malaysia
Australia
Rest of Asia Pacific
Latin America
Argentina
Brazil
Mexico
Rest of Latin America
Middle East & Africa
UAE
Saudi Arabia
Israel
South Africa
Rest of Middle East & Africa

Product Code: PM4793

1. Introduction

1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
1.2. Stakeholders

2. Executive Summary

2.1. Market Highlights

3. Research Methodology

3.1. Overview
- 3.1.1. Data Mining
3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources

4. Global Anorexiants Market Insights

4.1. Anorexiants Market - End User Snapshot
4.2. Anorexiants Market Dynamics
- 4.2.1. Drivers and Opportunities
  - 4.2.1.1. The presence of lower physical activity in the population
  - 4.2.1.2. Increase in the demand for weight-loss drugs
- 4.2.2. Restraints and Challenges
  - 4.2.2.1. Regulatory hurdles and side effects
4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
4.4. PESTEL Analysis
4.5. Anorexiants Market End User Trends
4.6. Value Chain Analysis
4.7. COVID-19 Impact Analysis

5. Global Anorexiants Market, by Drug Class

5.1. Key Findings
5.2. Introduction
- 5.2.1. Global Anorexiants Market, by Drug Class, 2019-2032 (USD Million)
5.3. Catecholamines
- 5.3.1. Global Anorexiants Market, by Catecholamines, by Region, 2019-2032 (USD Million)
5.4. Serotonin
- 5.4.1. Global Anorexiants Market, by Serotonin, by Region, 2019-2032 (USD Million)

6. Global Anorexiants Market, by Route of Admission

6.1. Key Findings
6.2. Introduction
- 6.2.1. Global Anorexiants Market, by Route of Admission, 2019-2032 (USD Million)
6.3. Oral
- 6.3.1. Global Anorexiants Market, by Oral, by Region, 2019-2032 (USD Million)
6.4. Subcutaneous
- 6.4.1. Global Anorexiants Market, by Subcutaneous, by Region, 2019-2032 (USD Million)

7. Global Anorexiants Market, by End User

7.1. Key Findings
7.2. Introduction
- 7.2.1. Global Anorexiants Market, by End User, 2019-2032 (USD Million)
7.3. Institutional sales
- 7.3.1. Global Anorexiants Market, by Institutional sales, By Region, 2019-2032 (USD Million)
7.4. Hospitals
- 7.4.1. Global Anorexiants Market, by Hospitals, By Region, 2019-2032 (USD Million)
7.5. Clinics
- 7.5.1. Global Anorexiants Market, by Clinics, By Region, 2019-2032 (USD Million)
7.6. Retail sales
- 7.6.1. Global Anorexiants Market, by Retail sales, By Region, 2019-2032 (USD Million)
7.7. Online pharmacies
- 7.7.1. Global Anorexiants Market, by Online pharmacies, By Region, 2019-2032 (USD Million)
7.8. Mail Order Pharmacies
- 7.8.1. Global Anorexiants Market, by Mail Order Pharmacies, By Region, 2019-2032 (USD Million)

8. Global Anorexiants Market, by Geography

8.1. Key findings
8.2. Introduction
- 8.2.1. Anorexiants Market Assessment, By Geography, 2019-2032 (USD Million)
8.3. Anorexiants Market - North America
- 8.3.1. North America: Anorexiants Market, by Drug Class, 2019-2032 (USD Million)
- 8.3.2. North America: Anorexiants Market, by End User, 2019-2032 (USD Million)
- 8.3.3. North America: Anorexiants Market, by Route of Admission, 2019-2032 (USD Million)
- 8.3.4. Anorexiants Market - U.S.
  - 8.3.4.1. U.S.: Anorexiants Market, by Drug Class, 2019-2032 (USD Million)
  - 8.3.4.2. U.S.: Anorexiants Market, by End User, 2019-2032 (USD Million)
  - 8.3.4.3. U.S.: Anorexiants Market, by Route of Admission, 2019-2032 (USD Million)
- 8.3.5. Anorexiants Market - Canada
  - 8.3.5.1. Canada: Anorexiants Market, by Drug Class, 2019-2032 (USD Million)
  - 8.3.5.2. Canada.: Anorexiants Market, by End User, 2019-2032 (USD Million)
  - 8.3.5.3. Canada: Anorexiants Market, by Route of Admission, 2019-2032 (USD Million)
8.4. Anorexiants Market - Europe
- 8.4.1. Europe: Anorexiants Market, by Drug Class, 2019-2032 (USD Million)
- 8.4.2. Europe.: Anorexiants Market, by End User, 2019-2032 (USD Million)
- 8.4.3. Europe: Anorexiants Market, by Route of Admission, 2019-2032 (USD Million)
- 8.4.4. Anorexiants Market - UK
  - 8.4.4.1. UK: Anorexiants Market, by Drug Class, 2019-2032 (USD Million)
  - 8.4.4.2. UK.: Anorexiants Market, by End User, 2019-2032 (USD Million)
  - 8.4.4.3. UK: Anorexiants Market, by Route of Admission, 2019-2032 (USD Million)
- 8.4.5. Anorexiants Market - France
  - 8.4.5.1. France: Anorexiants Market, by Drug Class, 2019-2032 (USD Million)
  - 8.4.5.2. France.: Anorexiants Market, by End User, 2019-2032 (USD Million)
  - 8.4.5.3. France: Anorexiants Market, by Route of Admission, 2019-2032 (USD Million)
- 8.4.6. Anorexiants Market - Germany
  - 8.4.6.1. Germany: Anorexiants Market, by Drug Class, 2019-2032 (USD Million)
  - 8.4.6.2. Germany.: Anorexiants Market, by End User, 2019-2032 (USD Million)
  - 8.4.6.3. Germany: Anorexiants Market, by Route of Admission, 2019-2032 (USD Million)
- 8.4.7. Anorexiants Market - Italy
  - 8.4.7.1. Italy: Anorexiants Market, by Drug Class, 2019-2032 (USD Million)
  - 8.4.7.2. Italy.: Anorexiants Market, by End User, 2019-2032 (USD Million)
  - 8.4.7.3. Italy: Anorexiants Market, by Route of Admission, 2019-2032 (USD Million)
- 8.4.8. Anorexiants Market - Spain
  - 8.4.8.1. Spain: Anorexiants Market, by Drug Class, 2019-2032 (USD Million)
  - 8.4.8.2. Spain.: Anorexiants Market, by End User, 2019-2032 (USD Million)
  - 8.4.8.3. Spain: Anorexiants Market, by Route of Admission, 2019-2032 (USD Million)
- 8.4.9. Anorexiants Market - Netherlands
  - 8.4.9.1. Netherlands: Anorexiants Market, by Drug Class, 2019-2032 (USD Million)
  - 8.4.9.2. Netherlands.: Anorexiants Market, by End User, 2019-2032 (USD Million)
  - 8.4.9.3. Netherlands: Anorexiants Market, by Route of Admission, 2019-2032 (USD Million)
- 8.4.10. Anorexiants Market - Russia
  - 8.4.10.1. Russia: Anorexiants Market, by Drug Class, 2019-2032 (USD Million)
  - 8.4.10.2. Russia.: Anorexiants Market, by End User, 2019-2032 (USD Million)
  - 8.4.10.3. Russia: Anorexiants Market, by Route of Admission, 2019-2032 (USD Million)
8.5. Anorexiants Market - Asia Pacific
- 8.5.1. Asia Pacific: Anorexiants Market, by Drug Class, 2019-2032 (USD Million)
- 8.5.2. Asia Pacific.: Anorexiants Market, by End User, 2019-2032 (USD Million)
- 8.5.3. Asia Pacific: Anorexiants Market, by Route of Admission, 2019-2032 (USD Million)
- 8.5.4. Anorexiants Market - China
  - 8.5.4.1. China: Anorexiants Market, by Drug Class, 2019-2032 (USD Million)
  - 8.5.4.2. China.: Anorexiants Market, by End User, 2019-2032 (USD Million)
  - 8.5.4.3. China: Anorexiants Market, by Route of Admission, 2019-2032 (USD Million)
- 8.5.5. Anorexiants Market - India
  - 8.5.5.1. India: Anorexiants Market, by Drug Class, 2019-2032 (USD Million)
  - 8.5.5.2. India.: Anorexiants Market, by End User, 2019-2032 (USD Million)
  - 8.5.5.3. India: Anorexiants Market, by Route of Admission, 2019-2032 (USD Million)
- 8.5.6. Anorexiants Market - Malaysia
  - 8.5.6.1. Malaysia: Anorexiants Market, by Drug Class, 2019-2032 (USD Million)
  - 8.5.6.2. Malaysia.: Anorexiants Market, by End User, 2019-2032 (USD Million)
  - 8.5.6.3. Malaysia: Anorexiants Market, by Route of Admission, 2019-2032 (USD Million)
- 8.5.7. Anorexiants Market - Japan
  - 8.5.7.1. Japan: Anorexiants Market, by Drug Class, 2019-2032 (USD Million)
  - 8.5.7.2. Japan.: Anorexiants Market, by End User, 2019-2032 (USD Million)
  - 8.5.7.3. Japan: Anorexiants Market, by Route of Admission, 2019-2032 (USD Million)
- 8.5.8. Anorexiants Market - Indonesia
  - 8.5.8.1. Indonesia: Anorexiants Market, by Drug Class, 2019-2032 (USD Million)
  - 8.5.8.2. Indonesia.: Anorexiants Market, by End User, 2019-2032 (USD Million)
  - 8.5.8.3. Indonesia: Anorexiants Market, by Route of Admission, 2019-2032 (USD Million)
- 8.5.9. Anorexiants Market - South Korea
  - 8.5.9.1. South Korea: Anorexiants Market, by Drug Class, 2019-2032 (USD Million)
  - 8.5.9.2. South Korea.: Anorexiants Market, by End User, 2019-2032 (USD Million)
  - 8.5.9.3. South Korea: Anorexiants Market, by Route of Admission, 2019-2032 (USD Million)
8.6. Anorexiants Market - Middle East & Africa
- 8.6.1. Middle East & Africa: Anorexiants Market, by Drug Class, 2019-2032 (USD Million)
- 8.6.2. Middle East & Africa.: Anorexiants Market, by End User, 2019-2032 (USD Million)
- 8.6.3. Middle East & Africa: Anorexiants Market, by Route of Admission, 2019-2032 (USD Million)
- 8.6.4. Anorexiants Market - Saudi Arabia
  - 8.6.4.1. Saudi Arabia: Anorexiants Market, by Drug Class, 2019-2032 (USD Million)
  - 8.6.4.2. Saudi Arabia.: Anorexiants Market, by End User, 2019-2032 (USD Million)
  - 8.6.4.3. Saudi Arabia: Anorexiants Market, by Route of Admission, 2019-2032 (USD Million)
- 8.6.5. Anorexiants Market - UAE
  - 8.6.5.1. UAE: Anorexiants Market, by Drug Class, 2019-2032 (USD Million)
  - 8.6.5.2. UAE.: Anorexiants Market, by End User, 2019-2032 (USD Million)
  - 8.6.5.3. UAE: Anorexiants Market, by Route of Admission, 2019-2032 (USD Million)
- 8.6.6. Anorexiants Market - Israel
  - 8.6.6.1. Israel: Anorexiants Market, by Drug Class, 2019-2032 (USD Million)
  - 8.6.6.2. Israel.: Anorexiants Market, by End User, 2019-2032 (USD Million)
  - 8.6.6.3. Israel: Anorexiants Market, by Route of Admission, 2019-2032 (USD Million)
- 8.6.7. Anorexiants Market - South Africa
  - 8.6.7.1. South Africa: Anorexiants Market, by Drug Class, 2019-2032 (USD Million)
  - 8.6.7.2. South Africa.: Anorexiants Market, by End User, 2019-2032 (USD Million)
  - 8.6.7.3. South Africa: Anorexiants Market, by Route of Admission, 2019-2032 (USD Million)
8.7. Anorexiants Market - Latin America
- 8.7.1. Latin America: Anorexiants Market, by Drug Class, 2019-2032 (USD Million)
- 8.7.2. Latin America.: Anorexiants Market, by End User, 2019-2032 (USD Million)
- 8.7.3. Latin America: Anorexiants Market, by Route of Admission, 2019-2032 (USD Million)
- 8.7.4. Anorexiants Market - Mexico
  - 8.7.4.1. Mexico: Anorexiants Market, by Drug Class, 2019-2032 (USD Million)
  - 8.7.4.2. Mexico.: Anorexiants Market, by End User, 2019-2032 (USD Million)
  - 8.7.4.3. Mexico: Anorexiants Market, by Route of Admission, 2019-2032 (USD Million)
- 8.7.5. Anorexiants Market - Brazil
  - 8.7.5.1. Brazil: Anorexiants Market, by Drug Class, 2019-2032 (USD Million)
  - 8.7.5.2. Brazil.: Anorexiants Market, by End User, 2019-2032 (USD Million)
  - 8.7.5.3. Brazil: Anorexiants Market, by Route of Admission, 2019-2032 (USD Million)
- 8.7.6. Anorexiants Market - Argentina
  - 8.7.6.1. Argentina: Anorexiants Market, by Drug Class, 2019-2032 (USD Million)
  - 8.7.6.2. Argentina.: Anorexiants Market, by End User, 2019-2032 (USD Million)
  - 8.7.6.3. Argentina: Anorexiants Market, by Route of Admission, 2019-2032 (USD Million)

9. Competitive Landscape

9.1. Expansion and Acquisition Analysis
- 9.1.1. Expansion
- 9.1.2. Acquisitions
9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

10.1. AstraZeneca (UK)
- 10.1.1. Company Overview
- 10.1.2. Financial Performance
- 10.1.3. Product Benchmarking
- 10.1.4. Recent Development
10.2. Aurobindo Pharma (India)
- 10.2.1. Company Overview
- 10.2.2. Financial Performance
- 10.2.3. Product Benchmarking
- 10.2.4. Recent Development
10.3. Bausch Health Companies Inc. (Canada)
- 10.3.1. Company Overview
- 10.3.2. Financial Performance
- 10.3.3. Product Benchmarking
- 10.3.4. Recent Development
10.4. Cipla Inc. (US)
- 10.4.1. Company Overview
- 10.4.2. Financial Performance
- 10.4.3. Product Benchmarking
- 10.4.4. Recent Development
10.5. Currax Pharmaceuticals LLC (US)
- 10.5.1. Company Overview
- 10.5.2. Financial Performance
- 10.5.3. Product Benchmarking
- 10.5.4. Recent Development
10.6. Eisai Co., Ltd. (Japan)
- 10.6.1. Company Overview
- 10.6.2. Financial Performance
- 10.6.3. Product Benchmarking
- 10.6.4. Recent Development
10.7. F. Hoffmann-La Roche Ltd. (Switzerland)
- 10.7.1. Company Overview
- 10.7.2. Financial Performance
- 10.7.3. Product Benchmarking
- 10.7.4. Recent Development
10.8. GlaxoSmithKline plc (UK)
- 10.8.1. Company Overview
- 10.8.2. Financial Performance
- 10.8.3. Product Benchmarking
- 10.8.4. Recent Development
10.9. Johnson & Johnson Private Limited (US)
- 10.9.1. Company Overview
- 10.9.2. Financial Performance
- 10.9.3. Product Benchmarking
- 10.9.4. Recent Development
10.10. Lannett (US)
- 10.10.1. Company Overview
- 10.10.2. Financial Performance
- 10.10.3. Product Benchmarking
- 10.10.4. Recent Development
10.11. Merck & Co., Inc. (US)
- 10.11.1. Company Overview
- 10.11.2. Financial Performance
- 10.11.3. Product Benchmarking
- 10.11.4. Recent Development
10.12. Mylan N.V. (US)
- 10.12.1. Company Overview
- 10.12.2. Financial Performance
- 10.12.3. Product Benchmarking
- 10.12.4. Recent Development
10.13. Novartis AG (Switzerland)
- 10.13.1. Company Overview
- 10.13.2. Financial Performance
- 10.13.3. Product Benchmarking
- 10.13.4. Recent Development

Product Code: PM4793

List of Tables

Table 1 Global Anorexiants Market, by Drug Class, 2019-2032 (USD Million)
Table 2 Global Anorexiants Market, by Route of Admission, 2019-2032 (USD Million)
Table 3 Global Anorexiants Market, by End User, 2019-2032 (USD Million)
Table 4 Anorexiants Market Assessment, By Geography, 2019-2032 (USD Million)
Table 5 North America: Anorexiants Market, by Drug Class, 2019-2032 (USD Million)
Table 6 North America: Anorexiants Market, by Route of Admission, 2019-2032 (USD Million)
Table 7 North America: Anorexiants Market, by End User, 2019-2032 (USD Million)
Table 8 U.S.: Anorexiants Market, by Drug Class, 2019-2032 (USD Million)
Table 9 U.S.: Anorexiants Market, by Route of Admission, 2019-2032 (USD Million)
Table 10 U.S.: Anorexiants Market, by End User, 2019-2032 (USD Million)
Table 11 Canada: Anorexiants Market, by Drug Class, 2019-2032 (USD Million)
Table 12 Canada: Anorexiants Market, by Route of Admission, 2019-2032 (USD Million)
Table 13 Canada: Anorexiants Market, by End User, 2019-2032 (USD Million)
Table 14 Europe: Anorexiants Market, by Drug Class, 2019-2032 (USD Million)
Table 15 Europe: Anorexiants Market, by Route of Admission, 2019-2032 (USD Million)
Table 16 Europe: Anorexiants Market, by End User, 2019-2032 (USD Million)
Table 17 UK: Anorexiants Market, by Drug Class, 2019-2032 (USD Million)
Table 18 UK: Anorexiants Market, by Route of Admission, 2019-2032 (USD Million)
Table 19 UK: Anorexiants Market, by End User, 2019-2032 (USD Million)
Table 20 France: Anorexiants Market, by Drug Class, 2019-2032 (USD Million)
Table 21 France: Anorexiants Market, by Route of Admission, 2019-2032 (USD Million)
Table 22 France: Anorexiants Market, by End User, 2019-2032 (USD Million)
Table 23 Germany: Anorexiants Market, by Drug Class, 2019-2032 (USD Million)
Table 24 Germany: Anorexiants Market, by Route of Admission, 2019-2032 (USD Million)
Table 25 Germany: Anorexiants Market, by End User, 2019-2032 (USD Million)
Table 26 Italy: Anorexiants Market, by Drug Class, 2019-2032 (USD Million)
Table 27 Italy: Anorexiants Market, by Route of Admission, 2019-2032 (USD Million)
Table 28 Italy: Anorexiants Market, by End User, 2019-2032 (USD Million)
Table 29 Spain: Anorexiants Market, by Drug Class, 2019-2032 (USD Million)
Table 30 Spain: Anorexiants Market, by Route of Admission, 2019-2032 (USD Million)
Table 31 Spain: Anorexiants Market, by End User, 2019-2032 (USD Million)
Table 32 Netherlands: Anorexiants Market, by Drug Class, 2019-2032 (USD Million)
Table 33 Netherlands: Anorexiants Market, by Route of Admission, 2019-2032 (USD Million)
Table 34 Netherlands: Anorexiants Market, by End User, 2019-2032 (USD Million)
Table 35 Russia: Anorexiants Market, by Drug Class, 2019-2032 (USD Million)
Table 36 Russia: Anorexiants Market, by Route of Admission, 2019-2032 (USD Million)
Table 37 Russia: Anorexiants Market, by End User, 2019-2032 (USD Million)
Table 38 Asia Pacific: Anorexiants Market, by Drug Class, 2019-2032 (USD Million)
Table 39 Asia Pacific: Anorexiants Market, by Route of Admission, 2019-2032 (USD Million)
Table 40 Asia Pacific: Anorexiants Market, by End User, 2019-2032 (USD Million)
Table 41 China: Anorexiants Market, by Drug Class, 2019-2032 (USD Million)
Table 42 China: Anorexiants Market, by Route of Admission, 2019-2032 (USD Million)
Table 43 China: Anorexiants Market, by End User, 2019-2032 (USD Million)
Table 44 India: Anorexiants Market, by Drug Class, 2019-2032 (USD Million)
Table 45 India: Anorexiants Market, by Route of Admission, 2019-2032 (USD Million)
Table 46 India: Anorexiants Market, by End User, 2019-2032 (USD Million)
Table 47 Malaysia: Anorexiants Market, by Drug Class, 2019-2032 (USD Million)
Table 48 Malaysia: Anorexiants Market, by Route of Admission, 2019-2032 (USD Million)
Table 49 Malaysia: Anorexiants Market, by End User, 2019-2032 (USD Million)
Table 50 Japan: Anorexiants Market, by Drug Class, 2019-2032 (USD Million)
Table 51 Japan: Anorexiants Market, by Route of Admission, 2019-2032 (USD Million)
Table 52 Japan: Anorexiants Market, by End User, 2019-2032 (USD Million)
Table 53 Indonesia: Anorexiants Market, by Drug Class, 2019-2032 (USD Million)
Table 54 Indonesia: Anorexiants Market, by Route of Admission, 2019-2032 (USD Million)
Table 55 Indonesia: Anorexiants Market, by End User, 2019-2032 (USD Million)
Table 56 South Korea: Anorexiants Market, by Drug Class, 2019-2032 (USD Million)
Table 57 South Korea: Anorexiants Market, by Route of Admission, 2019-2032 (USD Million)
Table 58 South Korea: Anorexiants Market, by End User, 2019-2032 (USD Million)
Table 59 Middle East & Africa: Anorexiants Market, by Drug Class, 2019-2032 (USD Million)
Table 60 Middle East & Africa: Anorexiants Market, by Route of Admission, 2019-2032 (USD Million)
Table 61 Middle East & Africa: Anorexiants Market, by End User, 2019-2032 (USD Million)
Table 62 Saudi Arabia: Anorexiants Market, by Drug Class, 2019-2032 (USD Million)
Table 63 Saudi Arabia: Anorexiants Market, by Route of Admission, 2019-2032 (USD Million)
Table 64 Saudi Arabia: Anorexiants Market, by End User, 2019-2032 (USD Million)
Table 65 UAE: Anorexiants Market, by Drug Class, 2019-2032 (USD Million)
Table 66 UAE: Anorexiants Market, by Route of Admission, 2019-2032 (USD Million)
Table 67 UAE: Anorexiants Market, by End User, 2019-2032 (USD Million)
Table 68 Israel: Anorexiants Market, by Drug Class, 2019-2032 (USD Million)
Table 69 Israel: Anorexiants Market, by Route of Admission, 2019-2032 (USD Million)
Table 70 Israel: Anorexiants Market, by End User, 2019-2032 (USD Million)
Table 71 South Africa: Anorexiants Market, by Drug Class, 2019-2032 (USD Million)
Table 72 South Africa: Anorexiants Market, by Route of Admission, 2019-2032 (USD Million)
Table 73 South Africa: Anorexiants Market, by End User, 2019-2032 (USD Million)
Table 74 Latin America: Anorexiants Market, by Drug Class, 2019-2032 (USD Million)
Table 75 Latin America: Anorexiants Market, by Route of Admission, 2019-2032 (USD Million)
Table 76 Latin America: Anorexiants Market, by End User, 2019-2032 (USD Million)
Table 77 Mexico: Anorexiants Market, by Drug Class, 2019-2032 (USD Million)
Table 78 Mexico: Anorexiants Market, by Route of Admission, 2019-2032 (USD Million)
Table 79 Mexico: Anorexiants Market, by End User, 2019-2032 (USD Million)
Table 80 Brazil: Anorexiants Market, by Drug Class, 2019-2032 (USD Million)
Table 81 Brazil: Anorexiants Market, by Route of Admission, 2019-2032 (USD Million)
Table 82 Brazil: Anorexiants Market, by End User, 2019-2032 (USD Million)
Table 83 Argentina: Anorexiants Market, by Drug Class, 2019-2032 (USD Million)
Table 84 Argentina: Anorexiants Market, by Route of Admission, 2019-2032 (USD Million)
Table 85 Argentina: Anorexiants Market, by End User, 2019-2032 (USD Million)

List of Figures

Figure 1. Global Anorexiants Market, 2019-2032 (USD Million)
Figure 2. Integrated Ecosystem
Figure 3. Research Methodology: Top-Down & Bottom-Up Approach
Figure 4. Market by Geography
Figure 5. Porter's Five Forces
Figure 6. Market by Route of Admission
Figure 7. Global Anorexiants Market, by Route of Admission, 2022 & 2032 (USD Million)
Figure 8. Market by Drug Class
Figure 9. Global Anorexiants Market, by Drug Class, 2022 & 2032 (USD Million)
Figure 10. Market by End User
Figure 11. Global Anorexiants Market, by End User, 2022 & 2032 (USD Million)
Figure 12. Anorexiants Market Assessment, By Geography, 2019-2032 (USD Million)
Figure 13. Strategic Analysis - Anorexiants Market